US-based BioMed Realty Trust is to buy MEPC’s Granta Park in Cambridge for around £127m (€157.5m).
The 472,200 sq ft (43,868 m2) asset includes 11 buildings that are home to biotechnology and pharmaceutical companies such as MedImmune, PPD Global, UCB
